SCHEMBL10889047

SCHEMBL10889047

CC1NC(=O)NN=C1c1ccc(N2CCCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 9/20 0.52
▸ PDE3A Q14432 8/20 0.52
▸ PDE4A P27815 2/20 0.46
▸ PDE4B Q07343 2/20 0.46
▸ PDE4C Q08493 2/20 0.46
▸ PDE4D Q08499 2/20 0.46
▸ GPR119 Q8TDV5 2/20 0.42
▸ BRD4 O60885 1/20 0.41
▸ CREBBP Q92793 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ HRH3 Q9Y5N1 2/20 0.38
▸ PDE2A O00408 1/20 0.38
▸ PDE1A P54750 1/20 0.38
▸ PDE1B Q01064 1/20 0.38
▸ PDE1C Q14123 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10891315 0.89 PDE3B (0.67) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10888967 0.81 AKR1C3 (0.44) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10887128 0.80 PDE3B (0.42) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10887841 0.78 PDE3B (0.47) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL16156987 0.78 PDE3B (0.79) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7319060 0.77 PDE3B (0.46) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10809454 0.77 PDE3B (0.54) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL28628042 0.76 PDE3B (0.57) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7295733 0.75 PDE3B (0.52) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10815443 0.75 PDE3B (0.52) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4616015-A HYPOTENSIVE AGENT, ANTULCER AGENT, ANTICOAGULANT FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-10-07 — — US disclosed
EP-0122627-A2 Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-24 — — EP disclosed
Send feedback